BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or BPC 157 500MCG Capsules Simple Peptide BPC 157 has already hit the mainstream, but should it hit your bloodstream? BPC 157 + TB 500 Research Compound Capsules Pepsynth Labs Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review BPC 157 Before and After: 1 Amazing Transformation